Company Filing History:
Years Active: 2013
Title: The Innovative Contributions of Egvenia Alpert
Introduction
Egvenia Alpert is a notable inventor based in Jerusalem, Israel. He has made significant contributions to the field of pharmaceutical compositions, particularly in the treatment of ear disorders. His innovative approach focuses on non-invasive methods for delivering therapeutic agents to the ear.
Latest Patents
Egvenia Alpert holds 1 patent for his invention titled "Compositions and methods for treatment of ear disorders." This patent describes pharmaceutical compositions that facilitate the topical, non-invasive delivery of oligonucleotides to the ear. The invention aims to treat various ear disorders, including hearing loss due to chemical-induced ototoxicity, acoustic trauma, presbycusis, and microbial infections. The method involves administering a composition that includes an inhibitory oligonucleotide, a permeability enhancer, and a pharmaceutically acceptable carrier, which collectively work to reduce or inhibit the expression of genes associated with ear disorders.
Career Highlights
Egvenia Alpert is currently associated with Quark Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work is pivotal in exploring new therapeutic avenues for ear-related health issues.
Collaborations
Throughout his career, Alpert has collaborated with esteemed colleagues, including Igor Spivak and Amir Bar-Ilan. These partnerships have fostered a collaborative environment that enhances innovation and research in the field.
Conclusion
Egvenia Alpert's contributions to the treatment of ear disorders through innovative pharmaceutical compositions highlight his role as a leading inventor in the field. His work not only addresses significant health challenges but also paves the way for future advancements in ear health therapies.